|
1
|
Eiró N and Vizoso FJ: Inflammation and
cancer. World J Gastrointest Surg. 27:62–72. 2012. View Article : Google Scholar
|
|
2
|
Calcinotto A, Grioni M, Jachetti E, Curnis
F, Mondino A, Parmiani G, Corti A and Bellone M: Targeting TNF-α to
neoangiogenic vessels enhances lymphocyte infiltration in tumors
and increases the therapeutic potential of immunotherapy. J
Immunol. 188:2687–2694. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ikemoto S, Sugimura K, Yoshida N, Wada S,
Yamamoto K and Kishimoto T: TNF alpha, IL-1 beta and IL-6
production by peripheral blood monocytes in patients with renal
cell carcinoma. Anticancer Res. 20:317–321. 2000.PubMed/NCBI
|
|
4
|
Wu Y, Deng J, Rychahou PQ, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsushita S, Nitanda T, Furukawa T,
Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M,
Yamada Y, et al: The effect of a thymidine phosphorylase inhibitor
on angiogenesis and apoptosis in tumors. Cancer Res. 59:1911–1916.
1999.PubMed/NCBI
|
|
6
|
Fong D, Spizzo G, Gostner JM, Gastl G,
Moser P, Krammel C, Gerhard S, Rasse M and Laimer K: TROP2: A novel
prognostic marker in squamous cell carcinoma of the oral cavity.
Mod Pathol. 21:186–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fong D, Moser P, Krammel C, Gostner JM,
Margreiter R, Mitterer M, Gastl G and Spizzo G: High expression of
TROP2 correlates with poor prognosis in pancreatic cancer. Br J
Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mühlmann G, Spizzo G, Gostner J, Zitt M,
Maier H, Moser P, Gastl G, Zitt M, Müller HM, Margreiter R, et al:
TROP2 expression as prognostic marker for gastric carcinoma. J Clin
Pathol. 62:152–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bignotti E, Todeschini P, Calza S,
Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C,
Zanotti L, et al: Trop-2 overexpression as an independent marker
for poor overall survival in ovarian carcinoma patients. Eur J
Cancer. 46:944–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pak MG, Shin DH, Lee CH and Lee MK:
Significance of EpCAM and TROP2 expression in non-small cell lung
cancer. World J Surg Oncol. 10:532012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trerotola M, Rathore S, Goel HL, Li J,
Alberti S, Piantelli M, Adams D, Jiang Z and Languino LR: Trop-2
and alpha-2beta1 integrin surface receptors as markers of putative
human prostate cancer stem cells. Am J Transl Res. 2:135–144.
2010.PubMed/NCBI
|
|
12
|
Zhao P, Yu HZ and Cai JH: Clinical
investigation of TROP-2 as an independent biomarker and potential
therapeutic target in colon cancer. Mol Med Rep. 12:4364–4369.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stepan LP, Trueblood ES, Hale K, Babcook
J, Borges L and Sutherland CL: Expression of Trop2 cell surface
glycoprotein in normal and tumor tissues: Potential implications as
a cancer therapeutic target. J Histochem Cytochem. 59:701–710.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schnider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu
J and Sun Y: BRAF-activated long non-coding RNA contributes to cell
proliferation and activates autophagy in papillary thyroid
carcinoma. Oncol Lett. 8:1947–1952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer related inflammation, the seventh hallmark
of cancer: Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wolczyk D, Zaremba-Czogalla M,
Hryniewicz-Jankowska A, Tabola R, Grabowski K, Sikorski AF and
Augoff K: TNF-α promotes breast cancer cell migration and enhances
the concentration of membrane-associated proteases in lipid rafts.
Cell Oncol (Dordr). 39:353–363. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao ZL, Yang CC, Xu XH, et al:
Experimental study on TNF-α promoting invasion and metastasis of
oral cancer cells by regulating MMPs. Stomatology. 34:9–12.
2014.
|
|
19
|
Hong H, Jiang L, Lin Y, He C, Zhu G, Du Q,
Wang X, She F and Chen Y: TNF-alpha promotes lymphangiogenesis and
lymphatic metastasis of gallbladder cancer through the
ERK1/2/AP-1/VEGF-D pathway. BMC Cancer. 16:2402016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choo MK, Sakurai H, Koizumi K and Saiki I:
Stimulation of cultured colon 26 cells with TNF-alpha promotes lung
metastasis through the extracellular signal-regulated kinase
pathway. Cancer Lett. 230:47–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hagemann T, Wilson J, Kulbe H, Li NF,
Leinster DA, Charles K, Klemm F, Pukrop T, Binder C and Balkwill
FR: Macrophages induce invasiveness of epithelial cancer cells via
NF-kappaB and JNK. J Immunol. 175:1197–1205. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muthukumaran N, Miletti-González KE,
Ravindranath AK and Rodríguez-Rodríguez L: Tumor necrosis
factor-alpha differentially modulates CD44 expression in ovarian
cancer cells. Mol Cancer Res. 4:511–520. 2006. View Article : Google Scholar : PubMed/NCBI
|
